Improving Low-Income Access to Prescription Drugs Act of 2019
This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Subcommittee Hearings Held.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line